Successful use of maintenance electroconvulsive therapy in the treatment of clozapine-associated obsessive-compulsive symptoms in schizophrenia: A case report

Journal of ECT

Volumn 27, Issue 1, 2011, Pages e37-e38

  Rao, Naren P ^a   Antony, Abish ^a   Raveendranathan, Dhanya ^a   Venkatasubramanian, Ganesan ^a   Behere, Rishikesh V ^a   Varambally, Shivarama S ^a   Gangadhar, Bangalore N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Atypical antipsychotics; ECT; Maintenance ECT; Obsessive compulsive symptoms; Schizophrenia

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; OLANZAPINE; RISPERIDONE; SUXAMETHONIUM; THIOPENTAL; ZUCLOPENTHIXOL;

ADULT; ANAMNESIS; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; OBSESSIVE COMPULSIVE DISORDER; PSYCHOLOGICAL RATING SCALE; RELAPSE; SCHIZOPHRENIA; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 79952192796     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181ec0d64     Document Type: Article

References (12)

1. Ganesan V, Kumar TC, Khanna S. Obsessive-compulsive disorder and psychosis. Can J Psychiatry. 2001;46(8): 750-754.
2. Hwang MY, Kim SW, Yum SY, et al. Management of schizophrenia with obsessive-compulsive features. Psychiatr Clin North Am. 2009;32(4): 835-851.
3. Lim M, Park DY, Kwon JS, et al. Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacol. 2007;27(6): 712-713.
4. Braga RJ, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT. 2005;21(2): 75-83.
5. Casey DA, Davis MH. Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J. 1994;87(8): 862-864.
6. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11): 1006-1011.
7. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3): 189-198.
8. Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45(12): 1094-1099.
9. Sevincok L, Akoglu A, Kokcu F. Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophr Res. 2007;90(1-3): 198-202.
10. Kim SW, Shin IS, Kim JM, et al. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. Clin Neuropharmacol. 2009;32(4): 224-226.
11. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004;18(14): 989-1010.
12. Kim SW, Shin IS, Kim JM, et al. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. J Clin Psychopharmacol. 2008;28(3): 349-352.